Literature DB >> 9486834

Pediatric intramedullary spinal cord tumors: is surgery alone enough?

K Y Goh1, L Velasquez, F J Epstein.   

Abstract

Pediatric intramedullary spinal cord tumors occur infrequently with limited data on treatment strategies and outcome. Over an 11-year period, 44 patients with such tumors who were primarily managed by radical surgery were retrospectively reviewed. The majority of tumors (42/44, 95%) were in the cervical or thoracic spine and were histologically low grade. Gross total resection was achieved in 73% (32/44). At a median follow-up of 45 months, 11% (5/44) had severe weakness (modified McCormick scale IV-V), 66% (29/44) had mild-moderate deficits (I-III), and 16% (7/44) had sphincter dysfunction. Tumor recurrence rate was 18% (8/44) after a mean period of 54 months. Age, number of involved spinal cord segments and extent of surgical resection did not significantly impact on tumor recurrence rates (p = 0.28, 0.44 and 0.13, respectively). The only significant prognostic factor was histological type; mixed or higher grade tumors having a higher recurrence rate (p = 0.04). Radical surgery for intraspinal tumors can achieve long tumor-free survival without requiring adjuvant therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9486834     DOI: 10.1159/000121222

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  17 in total

1.  Management of intramedullary tumors in children: analysis of 82 operated cases.

Authors:  Sumit Bansal; Ashish Suri; Sachin A Borkar; Shashank Sharad Kale; Manmohan Singh; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2012-07-07       Impact factor: 1.475

Review 2.  Prognostic factors in intramedullary astrocytomas: a literature review.

Authors:  Vladimír Benes; Pavel Barsa; Vladimír Benes; Petr Suchomel
Journal:  Eur Spine J       Date:  2009-06-28       Impact factor: 3.134

Review 3.  Updates in the management of intradural spinal cord tumors: a radiation oncology focus.

Authors:  Rupesh Kotecha; Minesh P Mehta; Eric L Chang; Paul D Brown; John H Suh; Simon S Lo; Sunit Das; Haider H Samawi; Julia Keith; James Perry; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

4.  Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin.

Authors:  Jaume Mora; Ofelia Cruz; Sandra Gala; Ramon Navarro
Journal:  Neuro Oncol       Date:  2006-11-15       Impact factor: 12.300

Review 5.  Hemangioblastomas and other uncommon intramedullary tumors.

Authors:  D J Miller; I E McCutcheon
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 6.  Pediatric intramedullary spinal cord tumors: special considerations.

Authors:  J K Houten; H L Weiner
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 7.  Chemotherapy for intramedullary spinal cord tumors.

Authors:  C Balmaceda
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

8.  Pediatric primary intramedullary spinal cord glioblastoma.

Authors:  Robert Lober; Suash Sharma; Beverly Bell; Alan Free; Ramon Figueroa; Chris W Sheils; Mark Lee; John Cowell
Journal:  Rare Tumors       Date:  2010-09-30

9.  Surgical considerations of spinal ependymomas in the pediatric population.

Authors:  Wesley Hsu; Gustavo Pradilla; Shlomi Constantini; George I Jallo
Journal:  Childs Nerv Syst       Date:  2009-04-10       Impact factor: 1.475

10.  Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival.

Authors:  John R Crawford; Alejandra Zaninovic; Mariarita Santi; Elisabeth J Rushing; Cara H Olsen; Robert F Keating; Gilbert Vezina; Nadja Kadom; Roger J Packer
Journal:  J Neurooncol       Date:  2009-06-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.